scispace - formally typeset
C

Chien-Jen Chen

Researcher at Academia Sinica

Publications -  672
Citations -  75709

Chien-Jen Chen is an academic researcher from Academia Sinica. The author has contributed to research in topics: Hepatocellular carcinoma & Population. The author has an hindex of 128, co-authored 655 publications receiving 66360 citations. Previous affiliations of Chien-Jen Chen include University of Science and Technology & Michigan State University.

Papers
More filters
Journal ArticleDOI

Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

Leandra Abarca-Gómez, +1024 more
- 16 Dec 2017 - 
TL;DR: Trends in mean BMI have recently flattened in northwestern Europe and the high-income English-speaking and Asia-Pacific regions for both sexes, southwestern Europe for boys, and central and Andean Latin America for girls, and by contrast, the rise in BMI has accelerated in east and south Asia forboth sexes, and southeast Asia for boys.
Journal ArticleDOI

Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants

Mariachiara Di Cesare, +741 more
- 02 Apr 2016 - 
TL;DR: The posterior probability of meeting the target of halting by 2025 the rise in obesity at its 2010 levels, if post-2000 trends continue, is calculated.
Journal ArticleDOI

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

TL;DR: Elevated serum HBV DNA level (> or =10,000 copies/mL) is a strong risk predictor of hepatocellular carcinoma independent of HBeAg, serum alanine aminotransferase level, and liver cirrhosis.
Journal ArticleDOI

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants

Bin Zhou, +497 more
- 09 Apr 2016 - 
TL;DR: In this article, the authors used a Bayesian hierarchical model to estimate trends in diabetes prevalence, defined as fasting plasma glucose of 7.0 mmol/L or higher, or history of diagnosis with diabetes, or use of insulin or oral hypoglycaemic drugs in 200 countries and territories in 21 regions, by sex and from 1980 to 2014.